Academic Paper QA Specialist -- 2
Budget: $30 – $250 USD
Instructions for Freelance Reviewer: Manuscript Quality Assurance
Thank you for your assistance with this project. A LLM have prepared a draft manuscript for a network meta-analysis (NMA) on emerging biologic therapies for Hidradenitis Suppurativa (HS). The goal is for you to perform a detailed quality check to ensure the scientific rigor and accuracy of the analysis.
Your task is to act as an expert reviewer, focusing on the methodology, results, and presentation of the data. I have included a published PDF, "ahdb-01-038.pdf", to be used as a methodological and stylistic guide.
1. Statistical Methods and Core Assumptions
Please review the methodology and results sections to confirm that the statistical approach is sound and that all critical assumptions have been addressed.
Model and Analysis: Verify that the description of the NMA model is correct. The manuscript discusses both Bayesian and Frequentist approaches. Please confirm that the chosen approach is correctly described and that the reported outputs (e.g., Odds Ratios, Confidence Intervals, etc.) are appropriate for the model used.
Consistency and Transitivity: Critically assess the discussion of consistency testing. Check for a narrative discussion that justifies the core assumption of transitivity across the included trials by examining whether patient populations, baseline characteristics, and study designs are comparable enough for the indirect comparisons to be meaningful.
Heterogeneity and Ranking: Confirm that the methods for assessing heterogeneity are appropriate. Ensure that the explanation of treatment ranking (e.g., SUCRA values or P-scores) is correct and that the results presented in Table 4 logically follow from the primary outcome data.
2. Research and Data Integrity
This is a crucial area of review. Please cross-reference the data points and conclusions with published, peer-reviewed literature to confirm their accuracy.
Data Verification: Please cross-reference the data points in Table 1: Characteristics of Included Studies and Table 3: Primary Outcome (HiSCR) - Network Meta-Analysis Results with the actual published literature. I need you to confirm that participant numbers, intervention doses, and reported outcomes (Odds Ratios and Confidence Intervals) are accurate and have not been fabricated.
Inclusion/Exclusion: Check the search strategy and study selection sections. Confirm that the eligibility criteria (e.g., "excluding adalimumab," "English-language RCTs only") are consistently applied throughout the study characteristics and results.
Plausibility of Outcomes: Confirm that the reported Odds Ratios and Confidence Intervals for the primary outcome (HiSCR) are plausible given the data presented, particularly in light of the high placebo response often seen in HS clinical trials.
3. Figure and Table Generation
The figures were created using Python code and converted to CSV for use in plotting software. Please check their accuracy and consistency.
Figure 1 (PRISMA Flow Diagram): Verify that the structure and numbers in this diagram are consistent with the search and study selection process described in the results section.
Figure 2 (Cochrane RoB 2.0 Summary Plot): Double-check that the judgments (low, some concerns, high risk) in this figure accurately reflect the data in Table 2: Risk of Bias Assessment.
Figure 3 (Network Diagram): Ensure that the network geometry visually matches the number of studies and participants per treatment arm as described in the text and Table 1. For instance, nodes with more participants should be proportionally larger.
Figure 4 (Forest Plot): Critically review the forest plot to ensure that the point estimates and confidence intervals for each comparison are accurately plotted, and that the overall pooled estimate (the diamond) is placed and sized correctly.
Figure 5 (Funnel Plot): Evaluate the funnel plot's symmetry to assess for potential publication bias. The review should also confirm that the manuscript's interpretation of these effects is fair and supported by the visual evidence.
4. Overall Manuscript Compliance and Tone
PRISMA-NMA Checklist: Please confirm that the manuscript adheres to the PRISMA-NMA checklist for reporting. This is a comprehensive guideline to ensure all essential elements of the analysis are transparently reported.
APA 7th Edition: Verify that all aspects of the manuscript, including in-text citations, the reference list, and the formatting of tables and figures, strictly adhere to APA 7th edition guidelines.
Discussion of Bias: Evaluate whether the manuscript adequately discusses the potential influence of industry-funded trials and other biases (e.g., small-study effects). The discussion should be balanced and avoid overstating or understating the potential impact of these factors.
Deliverable
Please provide a detailed report outlining your findings. For any inaccuracies or inconsistencies, please provide a specific reference to the section and a clear explanation of what needs to be corrected. Thank you again for your expertise.
Thank you for your assistance with this project. A LLM have prepared a draft manuscript for a network meta-analysis (NMA) on emerging biologic therapies for Hidradenitis Suppurativa (HS). The goal is for you to perform a detailed quality check to ensure the scientific rigor and accuracy of the analysis.
Your task is to act as an expert reviewer, focusing on the methodology, results, and presentation of the data. I have included a published PDF, "ahdb-01-038.pdf", to be used as a methodological and stylistic guide.
1. Statistical Methods and Core Assumptions
Please review the methodology and results sections to confirm that the statistical approach is sound and that all critical assumptions have been addressed.
Model and Analysis: Verify that the description of the NMA model is correct. The manuscript discusses both Bayesian and Frequentist approaches. Please confirm that the chosen approach is correctly described and that the reported outputs (e.g., Odds Ratios, Confidence Intervals, etc.) are appropriate for the model used.
Consistency and Transitivity: Critically assess the discussion of consistency testing. Check for a narrative discussion that justifies the core assumption of transitivity across the included trials by examining whether patient populations, baseline characteristics, and study designs are comparable enough for the indirect comparisons to be meaningful.
Heterogeneity and Ranking: Confirm that the methods for assessing heterogeneity are appropriate. Ensure that the explanation of treatment ranking (e.g., SUCRA values or P-scores) is correct and that the results presented in Table 4 logically follow from the primary outcome data.
2. Research and Data Integrity
This is a crucial area of review. Please cross-reference the data points and conclusions with published, peer-reviewed literature to confirm their accuracy.
Data Verification: Please cross-reference the data points in Table 1: Characteristics of Included Studies and Table 3: Primary Outcome (HiSCR) - Network Meta-Analysis Results with the actual published literature. I need you to confirm that participant numbers, intervention doses, and reported outcomes (Odds Ratios and Confidence Intervals) are accurate and have not been fabricated.
Inclusion/Exclusion: Check the search strategy and study selection sections. Confirm that the eligibility criteria (e.g., "excluding adalimumab," "English-language RCTs only") are consistently applied throughout the study characteristics and results.
Plausibility of Outcomes: Confirm that the reported Odds Ratios and Confidence Intervals for the primary outcome (HiSCR) are plausible given the data presented, particularly in light of the high placebo response often seen in HS clinical trials.
3. Figure and Table Generation
The figures were created using Python code and converted to CSV for use in plotting software. Please check their accuracy and consistency.
Figure 1 (PRISMA Flow Diagram): Verify that the structure and numbers in this diagram are consistent with the search and study selection process described in the results section.
Figure 2 (Cochrane RoB 2.0 Summary Plot): Double-check that the judgments (low, some concerns, high risk) in this figure accurately reflect the data in Table 2: Risk of Bias Assessment.
Figure 3 (Network Diagram): Ensure that the network geometry visually matches the number of studies and participants per treatment arm as described in the text and Table 1. For instance, nodes with more participants should be proportionally larger.
Figure 4 (Forest Plot): Critically review the forest plot to ensure that the point estimates and confidence intervals for each comparison are accurately plotted, and that the overall pooled estimate (the diamond) is placed and sized correctly.
Figure 5 (Funnel Plot): Evaluate the funnel plot's symmetry to assess for potential publication bias. The review should also confirm that the manuscript's interpretation of these effects is fair and supported by the visual evidence.
4. Overall Manuscript Compliance and Tone
PRISMA-NMA Checklist: Please confirm that the manuscript adheres to the PRISMA-NMA checklist for reporting. This is a comprehensive guideline to ensure all essential elements of the analysis are transparently reported.
APA 7th Edition: Verify that all aspects of the manuscript, including in-text citations, the reference list, and the formatting of tables and figures, strictly adhere to APA 7th edition guidelines.
Discussion of Bias: Evaluate whether the manuscript adequately discusses the potential influence of industry-funded trials and other biases (e.g., small-study effects). The discussion should be balanced and avoid overstating or understating the potential impact of these factors.
Deliverable
Please provide a detailed report outlining your findings. For any inaccuracies or inconsistencies, please provide a specific reference to the section and a clear explanation of what needs to be corrected. Thank you again for your expertise.